Phibro Animal Health Corporation reported earnings results for the fourth quarter ended June 30, 2022. For the fourth quarter, the company reported sales was USD 255.3 million compared to USD 220.3 million a year ago. Net income was USD 7.5 million compared to USD 17.1 million a year ago.

Basic earnings per share from continuing operations was USD 0.18 compared to USD 0.42 a year ago. Diluted earnings per share from continuing operations was USD 0.18 compared to USD 0.42 a year ago.